Brief: New Randomized Controlled Trial Demonstrates The Efficacy Of Daxor’S BVA Guided-Care
13/11/2023 14:27
Nov 13 (Reuters) - Daxor Corp DXR.O :
* NEW RANDOMIZED CONTROLLED TRIAL DEMONSTRATES THE EFFICACY
OF
DAXOR’S BVA GUIDED-CARE IN HEART FAILURE PATIENTS
Source text for Eikon: ID:nGNX8Q98gW
Further company coverage: DXR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Daxor
See all newsNASDAQ RESUMED AT 02:03 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:58 PM
Brief: Daxor Corp Reaffirms Focus On Blood Volume Analysis Technology
Brief: Daxor Corporation Submits 510(K) To FDA For Next-Generation Blood Volume Analyzer
Brief: Daxor Corporation Streamlines Regulatory Strategy For Groundbreaking Diagnostic Device